Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, and Schizophrenia research and treatment.
Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings
Speech patterns during memory recall relates to early tau burden across adulthood
A generalizable data‐driven model of atrophy heterogeneity and progression in a memory clinic setting
APOE effects on regional tau in preclinical Alzheimer’s disease
Natural cubic splines for the analysis of Alzheimer's clinical trials
The genetic regulation of protein expression in cerebrospinal fluid
Tau positron emission tomography in preclinical Alzheimer’s disease
Cognitive outcomes are differentially associated with depression severity trajectories during psychotherapy treatment for late life major depressive disorder
Early stages of tau pathology and its associations with functional connectivity, atrophy and memory
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease
A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
Neuroanatomical spread of amyloid β and tau in Alzheimer’s disease: implications for primary prevention
The A4 study: <i>β</i>‐amyloid and cognition in 4432 cognitively unimpaired adults
Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer’s Disease Neuroimaging Initiative Depression Project
Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
Predicting diagnosis and cognition with <sup>18</sup>F‐AV‐1451 tau PET and structural MRI in Alzheimer's disease
F1‐03‐03: DISTINCT CONTRIBUTIONS OF BASELINE AND LONGITUDINAL AMYLOID PET MEASURES TO MEMORY DECLINE IN COGNITIVELY NORMAL OLDER ADULTS
The Brain Health Registry: An internet‐based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies
Comparing <sup>18</sup> F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: Results from the Brain Health Registry
DT‐01‐06: COGNITIVE DECLINE IN PRECLINICAL ALZHEIMER'S DISEASE: A COMPARISON AND SYNTHESIS OF LARGE INTERNATIONAL COHORTS
18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease
Plasma tau in Alzheimer disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Assessing risk for preclinical β‐amyloid pathology with <i>APOE</i>, cognitive, and demographic information